Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lukas Perkhofer

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
BMC Biology|March 21, 2023
TBX3 is dynamically expressed in pancreatic organogenesis and fine-tunes regenerationMichael Karl Melzer, Silvia Schirge, Johann Gout, et al.
Nature Communications|July 30, 2015
Loss of ATM accelerates pancreatic cancer formation and epithelial-mesenchymal transitionRonan Russell, Lukas Perkhofer, Stefan Liebau, et al.
United European Gastroenterology Journal|December 6, 2024
European guidelines for the diagnosis and treatment of pancreatic exocrine insufficiency: UEG, EPC, EDS, ESPEN, ESPGHAN, ESDO, and ESPCG evidence-based recommendationsJ Enrique Dominguez-Muñoz, Miroslav Vujasinovic, Daniel de la Iglesia, et al.
Stem Cell Research|September 16, 2016
Tbx3 fosters pancreatic cancer growth by increased angiogenesis and activin/nodal-dependent induction of stemnessLukas Perkhofer, Karolin Walter, Ivan G Costa, et al.
The American Journal of Gastroenterology|February 25, 2022
Green Tea Extract to Prevent Colorectal Adenomas, Results of a Randomized, Placebo-Controlled Clinical TrialThomas Seufferlein, Thomas J Ettrich, Stefan Menzler, et al.
Plos One|June 14, 2024
Prediction of resistance to bevacizumab plus FOLFOX in metastatic colorectal cancer-Results of the prospective multicenter PERMAD trialThomas Seufferlein, Ludwig Lausser, Alexander Stein, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 28, 2025
DKK3 Initially Preserves Acinar Integrity Through MEK-Fos Signaling, but Later Switches to an Oncogenic Role in Pancreatic CancerDharini Srinivasan, Elodie Roger, Lukas Perkhofer, et al.
United European Gastroenterology Journal|March 28, 2020
Pancreatic cancer-derived organoids - a disease modeling tool to predict drug responsePierre-Olivier Frappart, Karolin Walter, Johann Gout, et al.
The Journal of Pathology|February 5, 2025
Unveiling the intriguing relationship: oncogenic KRAS, morphological shifts, and mutational complexity in pancreatic mucinous cystic neoplasmsLucas-Alexander Schulte, Annika Beck, Ralf Marienfeld, et al.
Cancer Research|February 3, 2021
RINT1 Regulates SUMOylation and the DNA Damage Response to Preserve Cellular Homeostasis in Pancreatic CancerFrank Arnold, Johann Gout, Heike Wiese, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
BMC Biology|March 21, 2023
TBX3 is dynamically expressed in pancreatic organogenesis and fine-tunes regenerationMichael Karl Melzer, Silvia Schirge, Johann Gout, et al.
Nature Communications|July 30, 2015
Loss of ATM accelerates pancreatic cancer formation and epithelial-mesenchymal transitionRonan Russell, Lukas Perkhofer, Stefan Liebau, et al.
United European Gastroenterology Journal|December 6, 2024
European guidelines for the diagnosis and treatment of pancreatic exocrine insufficiency: UEG, EPC, EDS, ESPEN, ESPGHAN, ESDO, and ESPCG evidence-based recommendationsJ Enrique Dominguez-Muñoz, Miroslav Vujasinovic, Daniel de la Iglesia, et al.
Stem Cell Research|September 16, 2016
Tbx3 fosters pancreatic cancer growth by increased angiogenesis and activin/nodal-dependent induction of stemnessLukas Perkhofer, Karolin Walter, Ivan G Costa, et al.
The American Journal of Gastroenterology|February 25, 2022
Green Tea Extract to Prevent Colorectal Adenomas, Results of a Randomized, Placebo-Controlled Clinical TrialThomas Seufferlein, Thomas J Ettrich, Stefan Menzler, et al.
Plos One|June 14, 2024
Prediction of resistance to bevacizumab plus FOLFOX in metastatic colorectal cancer-Results of the prospective multicenter PERMAD trialThomas Seufferlein, Ludwig Lausser, Alexander Stein, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 28, 2025
DKK3 Initially Preserves Acinar Integrity Through MEK-Fos Signaling, but Later Switches to an Oncogenic Role in Pancreatic CancerDharini Srinivasan, Elodie Roger, Lukas Perkhofer, et al.
United European Gastroenterology Journal|March 28, 2020
Pancreatic cancer-derived organoids - a disease modeling tool to predict drug responsePierre-Olivier Frappart, Karolin Walter, Johann Gout, et al.
The Journal of Pathology|February 5, 2025
Unveiling the intriguing relationship: oncogenic KRAS, morphological shifts, and mutational complexity in pancreatic mucinous cystic neoplasmsLucas-Alexander Schulte, Annika Beck, Ralf Marienfeld, et al.
Cancer Research|February 3, 2021
RINT1 Regulates SUMOylation and the DNA Damage Response to Preserve Cellular Homeostasis in Pancreatic CancerFrank Arnold, Johann Gout, Heike Wiese, et al.
Pageof 6